CVS Health Corporation (CVSH34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 19 Oct 2026
Key indicators
| Last close | BRL 46.93 |
|---|---|
| 52-week range | 36.41 – 58.11 |
| Return, 1 month / 3 months | +1.6% / −13.3% |
| Return, 1 year / 3 years | +10.4% / +42.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 55 |
| Volatility (1 year) | 33.3% |
| Worst drawdown (1 year) | -22.1% |
| Average daily value traded | 0.01M BRL |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CVS Health Corporation is an American healthcare company based in Woonsocket, Rhode Island. It runs retail pharmacies and walk-in health clinics, manages prescription drug benefits for employers and health plans through its pharmacy benefit business, and provides health insurance through Aetna. Its customers include individual consumers, employers, insurers and government health programmes. The company combines pharmacy services, medical care and insurance under one organisation, serving communities across the United States.
CVS Health Corporation is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code CVSH34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CVS Health Corporation (CVSH34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 46.93 on 19 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 537 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.4% and over the last three months it fell 13.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.7% | ||
| From 52-week high | -15.0% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -13.3% | ||
| 6-month return | 23.0% | ||
| 12-month return, skipping the last month | 8.7% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.1% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M BRL | ||
| Zero-volume days | 6.7% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +8.6% |
|---|---|
| 1 month | +1.6% |
| 3 months | −13.3% |
| 6 months | +23.0% |
| 1 year | +10.4% |
| 3 years | +42.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 47.18 / 45.25 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jul 2026 | USD 0.2299 |
| 20 Apr 2026 | USD 0.2215 |
| 20 Jan 2026 | USD 0.2349 |
| 21 Oct 2025 | USD 0.2422 |
| 18 Jul 2025 | USD 0.2479 |
| 16 Apr 2025 | USD 0.2536 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.